Literature DB >> 32246999

Management of Chronic Abdominal Distension and Bloating.

Brian E Lacy1, David Cangemi2, Maria Vazquez-Roque2.   

Abstract

Abdominal bloating and distension are 2 of the most commonly reported gastrointestinal symptoms. Abdominal bloating is characterized by symptoms of trapped gas, abdominal pressure, and fullness. Abdominal distension is defined as a measurable increase in abdominal girth. These symptoms frequently co-exist, although they can occur separately. Defined by Rome IV criteria, functional abdominal bloating and distension commonly coincide with other functional gastrointestinal disorders, such as functional dyspepsia, irritable bowel syndrome, and functional constipation. Abdominal bloating and distension can develop for multiple reasons, including food intolerances, a previous infection that perturbed the intestinal microbiota, disordered visceral sensation, delayed intestinal transit, or an abnormal viscero-somatic reflux. Treatment can be challenging to patients and providers-no regimen has been consistently successful. Successful treatment involves identifying the etiology, assessing severity, educating and reassuring patients, and setting expectations. Therapeutic options include dietary changes, probiotics, antibiotics, prokinetic agents, antispasmodics, neuromodulators, and biofeedback. We review the epidemiology and effects of chronic bloating and distension and pathophysiology, discuss appropriate diagnostic strategies, and assess available treatment options.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGID; IBS; Pain; Therapy

Year:  2020        PMID: 32246999     DOI: 10.1016/j.cgh.2020.03.056

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  6 in total

1.  A Practical Approach to the Diagnosis and Treatment of Abdominal Bloating and Distension.

Authors:  David J Cangemi; Brian E Lacy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2022-02

2.  Effect of a Daily Collagen Peptide Supplement on Digestive Symptoms in Healthy Women: 2-Phase Mixed Methods Study.

Authors:  Mariette Abrahams; Rochez O'Grady; Janne Prawitt
Journal:  JMIR Form Res       Date:  2022-05-31

3.  Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.

Authors:  Navkiran T Tornkvist; Imran Aziz; William E Whitehead; Ami D Sperber; Olafur S Palsson; Jóhann Pall Hreinsson; Magnus Simrén; Hans Törnblom
Journal:  United European Gastroenterol J       Date:  2021-10-01       Impact factor: 4.623

4.  Helicobacter pylori infection and lactose intolerance increase expiratory hydrogen.

Authors:  Wolfgang J Schnedl; Nathalie Meier-Allard; Michael Schenk; Sonja Lackner; Dietmar Enko; Harald Mangge; Sandra J Holasek
Journal:  EXCLI J       Date:  2022-02-17       Impact factor: 4.068

Review 5.  Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.

Authors:  Eric D Shah; Brian E Lacy; William D Chey; Lin Chang; Darren M Brenner
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

6.  The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas-related symptoms and their impact on daily life among general population and irritable bowel syndrome.

Authors:  Martin Duracinsky; Sharon Archbold; Beatriz Lobo; Pascal Bessonneau; Frédérique Thonon; Javier Santos; Danila Guagnozzi; Nalin Payakachat; Benoit Coffin; Fernando Azpiroz; Peter J Whorwell; Olivier Chassany
Journal:  Neurogastroenterol Motil       Date:  2021-06-18       Impact factor: 3.960

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.